Storax Protected Oxygen-Glucose Deprivation/Reoxygenation Induced Primary Astrocyte Injury by Inhibiting NF-κB Activation in vitro

Stroke is the second leading cause of death and the leading cause of long-term disability in the world. There is an urgent unmet need to develop a range of neuroprotective strategies to restrain the damage that occurs in the hours and days following a stroke. Storax, a natural resin extracted from i...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Meng Zhang, Yan Ma, Lijuan Chai, Haoping Mao, Junhua Zhang, Xiang Fan
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2019-01-01
Rangatū:	Frontiers in Pharmacology
Ngā marau:	storax astrocyte ischemia/reperfusion NF-κB ischemic stroke
Urunga tuihono:	https://www.frontiersin.org/article/10.3389/fphar.2018.01527/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!